Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents-Reference-Cited by-同舟云学术

Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents

Published:2023-01 Issue: Volume:187 Page:106568
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Hashemi Mehrdad,Mirdamadi Motahare Sadat Ayat,Talebi Yasmin,Khaniabad Nasrin,Banaei Gooya,Daneii Pouria,Gholami Sadaf,Ghorbani Amin,Tavakolpournegari Alireza,Farsani Zoheir Mohammadian,Zarrabi Ali,Nabavi Noushin,Zandieh Mohammad Arad,Rashidi Mohsen,Taheriazam Afshin,Entezari Maliheh,Khan Haroon

Publisher

Elsevier BV

Subject

Pharmacology

Reference349 articles.

1. miR-552: an important post-transcriptional regulator that affects human cancer;Zou;J. Cancer,2020

2. Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence;Paskeh;Int. J. Biol. Macromol.,2021

3. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators;Ashrafizadeh;Cell. Signal.,2021

4. The oncogenic role of miR-155 in breast CancermiR-155 and breast cancer;Mattiske,2012

5. Combinatorial microRNA target predictions;Krek,2005

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An updated review on the development of a nanomaterial-based field-effect transistor-type biosensors to detect exosomes for cancer diagnosis;Talanta;2024-11

2. MicroRNA-21 (miR-21) in breast cancer: From apoptosis dysregulation to therapeutic opportunities;Pathology - Research and Practice;2024-10

3. Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view;Functional & Integrative Genomics;2024-09-02

4. microRNA 21 and long non-coding RNAs interplays underlie cancer pathophysiology: A narrative review;Non-coding RNA Research;2024-09

5. Engineering supramolecular dynamics of self-assembly and turnover of oncogenic microRNAs to drive their synergistic destruction in tumor models;Biomaterials;2024-09